{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:16:33Z","timestamp":1792844193443,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00198-017-4267-x","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T18:36:52Z","timestamp":1508351812000},"page":"511-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Asfotase alfa treatment for 1\u00a0year in a 16\u00a0year-old male with severe childhood hypophosphatasia"],"prefix":"10.1007","volume":"29","author":[{"given":"S. A.","family":"Bowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. H.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"4267_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone 102:15\u201325","journal-title":"Bone"},{"issue":"4","key":"4267_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"4267_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/10408369109106863","volume":"28","author":"AM Caswell","year":"1991","unstructured":"Caswell AM, Whyte MP, Russell RGG (1991) Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects. Crit Rev Clin Lab Sci 28(3):195\u2013232","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4267_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC et al (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients. Bone 75:229\u2013239","journal-title":"Bone"},{"issue":"10","key":"4267_CR5","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/jbmr.454","volume":"26","author":"D Wenkert","year":"2011","unstructured":"Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL et al (2011) Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 26(10):2389\u20132398","journal-title":"J Bone Miner Res"},{"issue":"10","key":"4267_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366(10):904\u2013913","journal-title":"N Engl J Med"},{"issue":"1","key":"4267_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A et al (2016) Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab 101(1):334\u2013342","journal-title":"J Clin Endocrinol Metab"},{"key":"4267_CR8","doi-asserted-by":"publisher","unstructured":"Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al (2016) Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1(9):e85971. https:\/\/doi.org\/10.1172\/jci.insight.85971","DOI":"10.1172\/jci.insight.85971"},{"key":"4267_CR9","unstructured":"Kishnani PS, Madson KL, Whyte MP, Gayron M, Fujita K, Rockman-Greenberg C (2016) Biochemical and physical function outcomes in adolescents and adults with hypophosphatasia treated with asfotase alfa for up to 4 years: interim results from a phase II study. In: Presented at ENDO 2016, Boston, Massachusetts, 1\u20134 April 2016"},{"key":"4267_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","volume":"93","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Wenkert D, Zhang F (2016) Hypophosphatasia: natural history study of 101 affected children investigated at one research center. Bone 93:125\u2013138","journal-title":"Bone"},{"key":"4267_CR11","doi-asserted-by":"publisher","unstructured":"Whyte MP (2000) Hypophosphatasia. The genetics of osteoporosis and metabolic bone disease, Humana Press, Totowa, p. 335\u2013356. https:\/\/doi.org\/10.1007\/978-59259-033-9_18","DOI":"10.1007\/978-59259-033-9_18"},{"issue":"Supplement 3","key":"4267_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1542\/peds.102.S3.507","volume":"102","author":"V Abbassi","year":"1998","unstructured":"Abbassi V (1998) Growth and normal puberty. Pediatrics 102(Supplement 3):507\u2013511","journal-title":"Pediatrics"},{"key":"4267_CR13","doi-asserted-by":"publisher","unstructured":"Collins MT (2006) Spectrum and natural history of fibrous dysplasia of bone. J Bone Miner Res 21(S2). https:\/\/doi.org\/10.1359\/jbmr.06s219","DOI":"10.1359\/jbmr.06s219"},{"issue":"4","key":"4267_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","volume":"18","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP et al (2003) Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18(4):624\u2013636","journal-title":"J Bone Miner Res"},{"issue":"16","key":"4267_CR15","doi-asserted-by":"publisher","first-page":"E471","DOI":"10.1097\/01.brs.0000174277.03526.de","volume":"30","author":"R Arun","year":"2005","unstructured":"Arun R, Khazim R, Webb JK, Burn J (2005) Scoliosis in association with infantile hypophosphatasia: a case study in two siblings. Spine 30(16):E471\u2013E4E6","journal-title":"Spine"},{"issue":"4","key":"4267_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Mill\u00e1n","year":"2016","unstructured":"Mill\u00e1n JL, Whyte MP (2016) Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98(4):398\u2013416","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"4267_CR17","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160\u20133169","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4267-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T21:00:15Z","timestamp":1659646815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4267-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4267"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4267-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The patient\u2019s parent provided written informed consent for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}